Onconova Therapeutics, Inc. (NASDAQ: ONTX), stock rising above the skies in the pre-market

Related Topics

Facebook
Twitter
LinkedIn
WhatsApp

Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biotechnology corporation dedicated to the research and production of innovative cancer therapy drugs surged over 31% at $0.38 in pre-market trading Tuesday, on no news.

However, recently the company announced the registration with the U.S. of an Investigational New Drug (IND) application Food and Drug Administration (FDA) for the patented, differentiated, first-in-class multi-kinase inhibitor of the Business, ON 123300. The IND is seeking permission to launch a Phase 1 trial with ON 123300 in patients with HR+ HER 2-metastatic breast cancer with resistance to licenced second-generation CDK4/6 inhibitors for relapsed/refractory advanced cancer.

Leave a Comment

Your email address will not be published.

Top ev stock

Five Top EV Stocks to Buy Right Now

The push towards electrification and decarbonization has never been more apparent. With governments and international institutions on the same page as climate change activists, the

Latest Posts